Athyrium Capital Management, LP Rvl Pharmaceuticals PLC Transaction History

Athyrium Capital Management, LP

  • $4.1 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$1.02 - $1.39 $14.9 Million - $20.3 Million
14,600,444 New
14,600,444 $16.6 Million
Q1 2023

May 15, 2023
SELL
$1.02 - $1.39 $14.9 Million - $20.3 Million
-14,600,444 Closed
0 $0
Q3 2022

Nov 14, 2022
BUY
$1.28 - $2.91 $8.26 Million - $18.8 Million
6,451,612 Added 79.17%
14,600,444 $30.7 Million
Q4 2021

Feb 14, 2022
BUY
$0.98 - $3.06 $7.99 Million - $24.9 Million
8,148,832 New
8,148,832 $8.8 Million

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Athyrium Capital Management, LP Portfolio

Follow Athyrium Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athyrium Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athyrium Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email